Metabolic and bariatric surgery achieves 70% steatohepatitis remission in patients with MAFLD
Bariatric surgery shows significant improvements for liver disease and diabetes
This meta-analysis of 71,904 patients with biopsy or elastography-confirmed MAFLD found that metabolic and bariatric surgery leads to signif…
Metabolic surgery can help patients with fatty liver disease achieve remission of both liver inflammation and type 2 diabetes.
In Silico Modeling Predicts Fezolinetant Hepatotoxicity Risk in MAFLD Population
Could a menopause drug harm the liver? A computer model offers clues
Quantitative systems toxicology modeling simulated fezolinetant hepatotoxicity in virtual populations.
A computer model predicts a menopause drug might cause rare liver injury in people with fatty liver disease, but higher doses could be safer…